Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Filter articles using the following links
Financial press releases
Events & presentations
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
26 October 2018
GenSight Biologics enrolls first subject in first-in-man PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa
24 October 2018
GenSight Biologics Reports its Cash Position as of September 30, 2018
18 October 2018
GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
12 October 2018
GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology
09 October 2018
GenSight Biologics to participate in multiple upcoming investor conferences
22 Nov 2018 - 23 Nov 2018
Salon Actionaria 2018, Paris, France
23 Oct 2018 - 24 Oct 2018
2nd Annual Gene Therapy for Rare Disorders Europe, London, UK
13 September 2018
GenSight Biologics provides an update on the clinical and regulatory pathways for GS010
25 Oct 2018
Ophthalmology Innovation Summit @ AAO, Chicago (IL)
27 Oct 2018 - 30 Oct 2018
American Academy of Ophthalmology, Chicago (IL)
View previous 9 articles
1
…
22
23
24
25
26
27
28
29
30
31
32
…
40
View next 9 articles
Go back to the page of the page